Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Asthma

Free Subscription Articles published in Ann Allergy Asthma Immunol Retrieve available abstracts of 292 articles: HTML format

Single Articles

October 2024
1. WEINBERGER MM, Hendeles L
   Biologics for asthma and comorbid nasal polyps.
   Ann Allergy Asthma Immunol. 2024;133:356-357.
   PubMed    
   
   
   
2. CORELLI ER, Peebles RS Jr
   Race toward more equitable pulmonary function testing?
   Ann Allergy Asthma Immunol. 2024;133:362-363.
   PubMed    
   
   
   
3. MCCULLOCH MR, Bothwell S, Brinton JT, Anderson WC 3rd, et al
   Effect of electronic medication monitoring on asthma outcomes in a multidisciplinary pediatric severe asthma clinic.
   Ann Allergy Asthma Immunol. 2024 Oct 1:S1081-1206(24)01533.
   PubMed    
   
   
   September 2024
4. BLOODWORTH MH, Staso PJ, Huang S, Farber-Eger E, et al
   Metabolic and weight components' impact on incident asthma using a real-world cohort.
   Ann Allergy Asthma Immunol. 2024 Sep 16:S1081-1206(24)01509.
   PubMed     Abstract available
   
   
   
5. CHAN R, Lipworth B
   Airway oscillometry in asthma - present and future perspectives.
   Ann Allergy Asthma Immunol. 2024 Sep 14:S1081-1206(24)01529.
   PubMed    
   
   
   
6. GLEESON PK, Morales KH, Kerlin MP, Fadugba OO, et al
   Asthma exacerbations in Aspergillus fumigatus-sensitized adults with asthma differs by race.
   Ann Allergy Asthma Immunol. 2024 Sep 9:S1081-1206(24)01504.
   PubMed     Abstract available
   
   
   
7. SIM DW, Choi S, Jeong J, Lee SY, et al
   Computed tomography-based measurements associated with rapid lung function decline in severe asthma.
   Ann Allergy Asthma Immunol. 2024 Sep 5:S1081-1206(24)01502.
   PubMed     Abstract available
   
   
   
8. KAIDASHEV I, Ditiatkovskaya E
   Managing Asthma and Allergies during the Russo-Ukrainian War.
   Ann Allergy Asthma Immunol. 2024 Sep 3:S1081-1206(24)00573.
   PubMed    
   
   
   
9. SHAMIM J
   The relationship of height and asthma.
   Ann Allergy Asthma Immunol. 2024;133:352.
   PubMed    
   
   
   
10. PHILIPENKO BS, Davis B, Cockcroft DW
    To stop or not to stop an asthma biologic, that is the question.
    Ann Allergy Asthma Immunol. 2024;133:236-237.
    PubMed    
    
    
    
11. BRIGHTLING CE, Caminati M, Llanos JP, Caveney S, et al
    Biomarkers and clinical outcomes after tezepelumab cessation: Extended follow-up from the 2-year DESTINATION study.
    Ann Allergy Asthma Immunol. 2024;133:310-317.
    PubMed     Abstract available
    
    
    August 2024
12. HAYASHI Y, Tanabe N, Shimizu K, Maetani T, et al
    Lower skeletal muscle density and airway structure on computed tomography in asthma (12/15 words).
    Ann Allergy Asthma Immunol. 2024 Aug 21:S1081-1206(24)00527.
    PubMed     Abstract available
    
    
    
13. HAGWOOD SR, Elliott M, Marshall GD
    Comparing Prevalence of Food Allergy in Exercise-induced Bronchoconstriction vs. Asthma.
    Ann Allergy Asthma Immunol. 2024 Aug 13:S1081-1206(24)00496.
    PubMed    
    
    
    
14. ROTBLAT D, Wei C, Reyna GC, Grabie Y, et al
    Impact of Cannabinoid Use on Acute Pulmonary Outcomes in Hospitalized Asthmatic Patients.
    Ann Allergy Asthma Immunol. 2024 Aug 3:S1081-1206(24)00486.
    PubMed    
    
    
    
15. MALDONADO-PUEBLA M, Ledford D, Cardet JC
    The minimal clinically important difference in the Asthma Impairment and Risk Questionnaire.
    Ann Allergy Asthma Immunol. 2024;133:123-124.
    PubMed    
    
    
    
16. STEWART K, Kuo CR, Chan R, Lipworth B, et al
    Evaluating an electronic device to monitor the type 2 high unified airway response to dupilumab.
    Ann Allergy Asthma Immunol. 2024;133:211-213.
    PubMed    
    
    
    July 2024
17. SOTO-RETES L, Milagro J, Crespo-Lessmann A, Curto E, et al
    Parasympathetic nervous system: a key role in control and mood disorders in patients with asthma.
    Ann Allergy Asthma Immunol. 2024 Jul 27:S1081-1206(24)00480.
    PubMed     Abstract available
    
    
    
18. FITZPATRICK AM, Mohammad AF, Desher K, Mutic AD, et al
    Clinical and inflammatory features of traffic-related diesel exposure in children with asthma.
    Ann Allergy Asthma Immunol. 2024 Jul 27:S1081-1206(24)00457.
    PubMed     Abstract available
    
    
    
19. HAN YY, Celedon JC
    The Effects of Violence and Related Stress on Asthma.
    Ann Allergy Asthma Immunol. 2024 Jul 26:S1081-1206(24)00479.
    PubMed     Abstract available
    
    
    
20. FRUEH L, Sharma R, Sheffield PE, Clougherty JE, et al
    Community Violence and Asthma: A Review.
    Ann Allergy Asthma Immunol. 2024 Jul 20:S1081-1206(24)00453.
    PubMed     Abstract available
    
    
    
21. CHIARELLA SE, Garcia-Guaqueta DP, Drake LY, Dixon RE, et al
    Sex differences in sociodemographic, clinical, and laboratory variables in childhood asthma: A birth cohort study.
    Ann Allergy Asthma Immunol. 2024 Jul 15:S1081-1206(24)00426.
    PubMed     Abstract available
    
    
    
22. TAJIRI T, Suzuki M, Nishiyama H, Ozawa Y, et al
    Efficacy of dupilumab for severe chronic rhinosinusitis with nasal polyps and asthma: A prospective study.
    Ann Allergy Asthma Immunol. 2024 Jul 5:S1081-1206(24)00422.
    PubMed     Abstract available
    
    
    
23. BERNSTEIN JA, Silver J, Packnett E, Lew CR, et al
    Real-world unified airway benefits of mepolizumab: effectiveness in patients with asthma and comorbid nasal polyps.
    Ann Allergy Asthma Immunol. 2024 Jul 5:S1081-1206(24)00421.
    PubMed     Abstract available
    
    
    
24. SIM S, Jang JH, Park HS
    Contribution of non-neuronal cholinergic system to T2-low airway inflammation in severe asthma.
    Ann Allergy Asthma Immunol. 2024;133:7-8.
    PubMed    
    
    
    
25. GUTIERREZ CG, Bukstein DA
    Functionality of the Asthma Impairment and Risk Questionnaire and its implications in shared decision-making.
    Ann Allergy Asthma Immunol. 2024;133:5-6.
    PubMed    
    
    
    
26. HARRIS D, Borish L
    How we treat type 2 low asthma.
    Ann Allergy Asthma Immunol. 2024;133:43-46.
    PubMed    
    
    
    
27. MULLUR J, Buchheit KM
    Correction to "Aspirin-exacerbated respiratory disease" by Mullur J and Buchheit KM (Ann Allergy Asthma Immunol 131 (2023) 317-324).
    Ann Allergy Asthma Immunol. 2024;133:118.
    PubMed    
    
    
    
28. CONWAY AE, White AA, Borish L, Shaker M, et al
    Eicosanoids, innate immunity, and alarmins in aspirin-exacerbated respiratory disease.
    Ann Allergy Asthma Immunol. 2024;133:13-15.
    PubMed    
    
    
    June 2024
29. ADELEKE S, Ongtengco A, Youssef C, Hardy P, et al
    Addressing Critical Barriers for Sustainability of Asthma Stock Inhaler Policy Implementation and Resultant Programming.
    Ann Allergy Asthma Immunol. 2024 Jun 26:S1081-1206(24)00373.
    PubMed     Abstract available
    
    
    
30. BAREILLE P, Forth R, Imber V, Bondarenko I, et al
    Once-Daily Fluticasone Furoate/Vilanterol Versus Once-Daily Fluticasone Furoate in Asthma Patients Aged 5-17 Years.
    Ann Allergy Asthma Immunol. 2024 Jun 25:S1081-1206(24)00376.
    PubMed     Abstract available
    
    
    
31. MISHRA PE, Han YY, Hill K, Rosser FJ, et al
    Persistent cat ownership and asthma in a longitudinal study of Puerto Rican youth.
    Ann Allergy Asthma Immunol. 2024 Jun 24:S1081-1206(24)00375.
    PubMed     Abstract available
    
    
    
32. ZAEH SE, Zimmerman ZE, Eakin MN, Chupp G, et al
    Adoption and Implementation of Maintenance and Reliever Therapy for Adults with Moderate to Severe Asthma.
    Ann Allergy Asthma Immunol. 2024 Jun 17:S1081-1206(24)00363.
    PubMed     Abstract available
    
    
    
33. ZEIGER JS, Silvers WS, Zeiger RS
    Comparison of Cannabis Knowledge, Attitudes, and Practice (KAP) between Allergists and Allergic and Asthmatic Patients.
    Ann Allergy Asthma Immunol. 2024 Jun 13:S1081-1206(24)00347.
    PubMed    
    
    
    
34. LIEBERMAN JA, Chu DK, Ahmed T, Dribin TE, et al
    Use of Vaccines in Patients Receiving Dupilumab, A Systematic Review and Expert Delphi Consensus Recommendation: A position paper of the American College of Allergy, Asthma and Immunology.
    Ann Allergy Asthma Immunol. 2024 Jun 5:S1081-1206(24)00337.
    PubMed     Abstract available
    
    
    
35. SEDAGHAT AR, Phillips KM
    Unifying the airway through multiomics.
    Ann Allergy Asthma Immunol. 2024;132:667-668.
    PubMed    
    
    
    May 2024
36. BELLANTI JA, Settipane RA
    Legacy of Congressman George Miller O'Brien: Advocate for the patient with asthma and allergic disease.
    Ann Allergy Asthma Immunol. 2024 May 31:S1081-1206(24)00308.
    PubMed    
    
    
    
37. PETERSEN M, Bingemann TA
    Correction to "Navigating allergic disease in military accessions: A crucial role for civilian allergists" (Ann Allergy Asthma Immunol 132 (2024) 547-548).
    Ann Allergy Asthma Immunol. 2024 May 18:S1081-1206(24)00285.
    PubMed    
    
    
    
38. CHUPP G, Murphy KR, Gandhi HN, Gilbert I, et al
    Asthma control in the United States: relationships between short-acting beta(2)-agonist and systemic corticosteroid use.
    Ann Allergy Asthma Immunol. 2024 May 11:S1081-1206(24)00287.
    PubMed     Abstract available
    
    
    
39. KLOEPFER KM, Kennedy JL
    Decoding viral infections and risk for asthma: Biomarkers or clinical histories?
    Ann Allergy Asthma Immunol. 2024;132:553-554.
    PubMed    
    
    
    
40. KATIAL RK, Hoyte FCL
    Comment on geographic variation in disease burden among patients with severe persistent asthma in the United States.
    Ann Allergy Asthma Immunol. 2024;132:551-552.
    PubMed    
    
    
    April 2024
41. TURI KN, Li Y, Xu Y, Gebretsadik T, et al
    The Association of Infant Urinary Adrenal Steroids with the Risk of Childhood Asthma Development.
    Ann Allergy Asthma Immunol. 2024 Apr 15:S1081-1206(24)00215.
    PubMed     Abstract available
    
    
    
42. WOO SD, Park HS, Yang EM, Ban GY, et al
    8-Iso-prostaglandin F2alpha as a biomarker of T2-low airway inflammation and remodeling in adult asthma.
    Ann Allergy Asthma Immunol. 2024 Apr 12:S1081-1206(24)00214.
    PubMed     Abstract available
    
    
    March 2024
43. MOTA D, Martins C, Puga N, Moreira A, et al
    Asthma and allergy screening in elite football athletes: is it worth it?
    Ann Allergy Asthma Immunol. 2024 Mar 29:S1081-1206(24)00205.
    PubMed    
    
    
    
44. LEE PH, An M, Hwang D, Jang AS, et al
    Impact of circulating angiomotin and angiostatin on clinical variables in patients with asthma.
    Ann Allergy Asthma Immunol. 2024 Mar 29:S1081-1206(24)00207.
    PubMed    
    
    
    
45. HUANG D, Zhang L, Liu Y, Wang J, et al
    Activated non-neuronal cholinergic system correlates with non-type 2 inflammation and exacerbations in severe asthma.
    Ann Allergy Asthma Immunol. 2024 Mar 16:S1081-1206(24)00150.
    PubMed     Abstract available
    
    
    
46. ZAHRAEI HN, Schleich F, Louis G, Gerday S, et al
    Evidence for two clusters among non-eosinophilic asthmatics.
    Ann Allergy Asthma Immunol. 2024 Mar 16:S1081-1206(24)00154.
    PubMed     Abstract available
    
    
    
47. CHIPPS BE, Zeiger RS, Beuther DA, Wise RA, et al
    Advancing assessment of asthma control with a composite tool: the Asthma Impairment and Risk Questionnaire.
    Ann Allergy Asthma Immunol. 2024 Mar 15:S1081-1206(24)00153.
    PubMed     Abstract available
    
    
    
48. LI Y, Hong X, Chandran A, Keet CA, et al
    Associations between cord blood acetaminophen biomarkers and childhood asthma with and without allergic comorbidities.
    Ann Allergy Asthma Immunol. 2024 Mar 12:S1081-1206(24)00143.
    PubMed     Abstract available
    
    
    
49. GWAK DY, Tea JC, Fatima FN, Palka JM, et al
    Contribution of caregiver and child anxiety and depressive symptoms to child asthma-related quality of life.
    Ann Allergy Asthma Immunol. 2024 Mar 6:S1081-1206(24)00141.
    PubMed     Abstract available
    
    
    February 2024
50. CETIN GP, Yilmaz I
    What should be the outcome of biological treatment in asthma: "Remission on Treatment" or "Super-responder".
    Ann Allergy Asthma Immunol. 2024 Feb 23:S1081-1206(24)00103.
    PubMed    
    
    
    
51. CHAN R, Duraikannu C, Thouseef MJ, Lipworth B, et al
    Lower paraspinal muscle density is associated with small airway dysfunction in women with persistent asthma.
    Ann Allergy Asthma Immunol. 2024 Feb 22:S1081-1206(24)00089.
    PubMed    
    
    
    
52. YAO Y, Yang Y, Wang J, Yu P, et al
    Proteomic and metabolomic proof of concept for unified airways in chronic rhinosinusitis and asthma.
    Ann Allergy Asthma Immunol. 2024 Feb 19:S1081-1206(24)00084.
    PubMed     Abstract available
    
    
    
53. NGO SY, Bothwell S, Brinton JT, Anderson WC 3rd, et al
    Preparing Adolescents for Independent Asthma Management: Gaps and Opportunities.
    Ann Allergy Asthma Immunol. 2024 Feb 17:S1081-1206(24)00086.
    PubMed    
    
    
    
54. MCCANN W, Murphy KR, Zeiger RS, Beuther DA, et al
    Assessing Meaningful Change in the Asthma Impairment and Risk Questionnaire.
    Ann Allergy Asthma Immunol. 2024 Feb 16:S1081-1206(24)00085.
    PubMed     Abstract available
    
    
    
55. AKAMATSU T, Shirai T, Okawa K, Hirai K, et al
    Improved small airway dysfunction in severe asthma with clinical remission by anti-IL-5/IL-5 receptor alpha.
    Ann Allergy Asthma Immunol. 2024 Feb 13:S1081-1206(24)00080.
    PubMed    
    
    
    
56. HAN YY, Rosser F, Acosta-Perez E, Canino G, et al
    Social vulnerability index, poverty, and asthma in a prospective study of Puerto Rican youth.
    Ann Allergy Asthma Immunol. 2024 Feb 5:S1081-1206(24)00075.
    PubMed    
    
    
    January 2024
57. BRACKEN AC, Oppenheimer JJ, Mosnaim GS, Rank MA, et al
    Simplifying asthma management in a university setting: a perspective.
    Ann Allergy Asthma Immunol. 2024 Jan 20:S1081-1206(24)00014.
    PubMed    
    
    
    
58. ZHOU X, Sampath V, Nadeau KC
    Effect of Air Pollution on Asthma.
    Ann Allergy Asthma Immunol. 2024 Jan 20:S1081-1206(24)00018.
    PubMed     Abstract available
    
    
    
59. CHEN C, Song X, Murdock DJ, Marcus A, et al
    Association between allergic conditions and COVID-19 susceptibility and outcomes.
    Ann Allergy Asthma Immunol. 2024 Jan 17:S1081-1206(24)00011.
    PubMed     Abstract available
    
    
    
60. ROSAS-SALAZAR C, Bacharier LB
    The biologic asthma response score: A blueprint to address biologic failure in severe asthma?
    Ann Allergy Asthma Immunol. 2024;132:7-8.
    PubMed    
    
    
    
61. SHAKER M, Golden DBK
    More than 80 years of excellence and collaboration in allergy ... and just getting started.
    Ann Allergy Asthma Immunol. 2024;132:3-4.
    PubMed    
    
    
    
62. LIEBERMAN JA
    Trials and tribulations of managing pediatric and adolescent asthma.
    Ann Allergy Asthma Immunol. 2024;132:1-2.
    PubMed    
    
    
    December 2023
63. AKEL MJ, Camargo CA Jr, Fujiogi M, Hasegawa K, et al
    Lack of health disparities during implementation of hospital-initiated care bundle among hospitalized adults with asthma.
    Ann Allergy Asthma Immunol. 2023 Dec 25:S1081-1206(23)01514.
    PubMed    
    
    
    
64. PEREZ-DE-LLANO L, Scelo G, Canonica GW, Chen W, et al
    Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma.
    Ann Allergy Asthma Immunol. 2023 Dec 25:S1081-1206(23)01508.
    PubMed     Abstract available
    
    
    
65. CAMARGO CA JR, Rane PB, Beck AF, Wang Y, et al
    Geographic Variation in Disease Burden Among Patients with Severe Persistent Asthma in the United States.
    Ann Allergy Asthma Immunol. 2023 Dec 21:S1081-1206(23)01501.
    PubMed     Abstract available
    
    
    
66. MOHAN A, Desai B, Lugogo N
    Analyzing Co-morbidities and their Influence on Severe Asthma: Another Missing Piece of the Puzzle Solved?
    Ann Allergy Asthma Immunol. 2023 Dec 20:S1081-1206(23)01500.
    PubMed    
    
    
    
67. ADGENT MA, Buth E, Norona-Zhou A, Szpiro AA, et al
    Maternal stressful life events during pregnancy and childhood asthma and wheeze.
    Ann Allergy Asthma Immunol. 2023 Dec 18:S1081-1206(23)01498.
    PubMed     Abstract available
    
    
    
68. CHU DK, Schneider L, Asiniwasis RN, Boguniewicz M, et al
    Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations.
    Ann Allergy Asthma Immunol. 2023 Dec 18:S1081-1206(23)01455.
    PubMed     Abstract available
    
    
    
69. ANAGNOSTOU A, Greenhawt M, Shaker M
    Improving Food Allergy Management: Control Asthma and Decrease Food Allergy Risk.
    Ann Allergy Asthma Immunol. 2023 Dec 12:S1081-1206(23)01495.
    PubMed    
    
    
    
70. STEPPE S, Stokes DC, Underhill C, Winders TA, et al
    Changing High-Risk Asthma in Memphis Through Partnership: Results from the CHAMP Program.
    Ann Allergy Asthma Immunol. 2023 Dec 9:S1081-1206(23)01486.
    PubMed     Abstract available
    
    
    
71. SIRCAR K, Hagen MB, Prezzato E, Hsu J, et al
    Opportunities to monitor disparities in asthma and other respiratory diseases using public health data.
    Ann Allergy Asthma Immunol. 2023;131:683-684.
    PubMed    
    
    
    
72. GRAYSON MH
    Congratulations to the 2023 American College of Allergy, Asthma and Immunology Annals Fellow-in-Training award winners.
    Ann Allergy Asthma Immunol. 2023;131:681-682.
    PubMed    
    
    
    November 2023
73. PETERS AT, Sagara H, Corren J, Domingo C, et al
    Impact of dupilumab across seasons in patients with type 2 uncontrolled, moderate-to-severe asthma.
    Ann Allergy Asthma Immunol. 2023 Nov 25:S1081-1206(23)01470.
    PubMed     Abstract available
    
    
    
74. SHERENIAN M, Biagini JM, Ryan P, Hershey GKK, et al
    What allergist/immunologists can do to limit the effects of air pollution on asthma and allergies.
    Ann Allergy Asthma Immunol. 2023 Nov 24:S1081-1206(23)01468.
    PubMed    
    
    
    
75. YANG Y, Kimura H, Yokota I, Makita H, et al
    Applicable predictive factors extracted from peak flow trajectory for the prediction of asthma exacerbation.
    Ann Allergy Asthma Immunol. 2023 Nov 23:S1081-1206(23)01464.
    PubMed     Abstract available
    
    
    
76. KIM BE, Hui-Beckman JW, Nevid MZ, Goleva E, et al
    Air pollutants contribute to epithelial barrier dysfunction and allergic diseases.
    Ann Allergy Asthma Immunol. 2023 Nov 23:S1081-1206(23)01462.
    PubMed     Abstract available
    
    
    
77. COREY KB, Moore R, Zuckerman AD, Littlejohn M, et al
    Persistent use of dupilumab in adults with asthma or chronic rhinosinusitis with nasal polyps.
    Ann Allergy Asthma Immunol. 2023 Nov 17:S1081-1206(23)01454.
    PubMed    
    
    
    
78. PHAM DD, Lee JH, Kwon HS, Song WJ, et al
    Prospective direct comparison of biological treatments on severe eosinophilic asthma: Findings from the PRISM study.
    Ann Allergy Asthma Immunol. 2023 Nov 15:S1081-1206(23)01402.
    PubMed     Abstract available
    
    
    
79. BLAISS M, Bleecker ER, Jacob-Nara J, Nair R, et al
    Real-world effectiveness of dupilumab in patients with asthma: findings from the United States ADVANTAGE study.
    Ann Allergy Asthma Immunol. 2023 Nov 13:S1081-1206(23)01399.
    PubMed     Abstract available
    
    
    
80. AGARWAL CD, Palka JM, Gajewski AJ, Khan DA, et al
    The Efficacy of Citalopram or Escitalopram in Patients with Asthma and Major Depressive Disorder.
    Ann Allergy Asthma Immunol. 2023 Nov 10:S1081-1206(23)01401.
    PubMed     Abstract available
    
    
    
81. GEVAERT P, Mullol J, Saenz R, Ko J, et al
    Omalizumab improves sinonasal outcomes in patients with chronic rhinosinusitis with nasal polyps regardless of allergic status.
    Ann Allergy Asthma Immunol. 2023 Nov 9:S1081-1206(23)01393.
    PubMed     Abstract available
    
    
    
82. CHEN M, Bacong AM, Feng C, Kikuta NT, et al
    Asthma heterogeneity amongst Asian American children: the California Health Interview Survey.
    Ann Allergy Asthma Immunol. 2023 Nov 8:S1081-1206(23)01395.
    PubMed     Abstract available
    
    
    
83. XU J, Rathkopf MM
    The cost of medication costs: Cost-related medication nonadherence in patients with asthma in the United States.
    Ann Allergy Asthma Immunol. 2023;131:538-539.
    PubMed    
    
    
    October 2023
84. PATEL D, Revier MD, Tambay A, Geng B, et al
    Implementation of a Pediatric Synchronous Multidisciplinary Severe Asthma Clinic and Real-World Outcomes.
    Ann Allergy Asthma Immunol. 2023 Oct 26:S1081-1206(23)01380.
    PubMed    
    
    
    
85. HO JK, Shaker M, Greenhawt M, Sadatsafavi M, et al
    Cost-effectiveness of budesonide-formoterol versus inhaled epinephrine in United States adults with mild asthma.
    Ann Allergy Asthma Immunol. 2023 Oct 23:S1081-1206(23)01352.
    PubMed     Abstract available
    
    
    
86. JOHNSON KM, Cheng L, Yin Y, Carter R, et al
    Impact of income-based public drug coverage deductibles on adherence to asthma medications.
    Ann Allergy Asthma Immunol. 2023 Oct 21:S1081-1206(23)01345.
    PubMed     Abstract available
    
    
    
87. YOSHIZATO R, Motomura Y, Fujita T, Babazono A, et al
    Secondhand smoking and pediatric asthma after respiratory syncytial virus or human metapneumovirus infection.
    Ann Allergy Asthma Immunol. 2023 Oct 18:S1081-1206(23)01342.
    PubMed    
    
    
    
88. KILPATRICK K, Ambrose CS, Lindsley AW, Oppenheimer J, et al
    At-Home Asthma Mortality Unchanged Despite Declining Mortality in Other Settings: US Death Certificate Data (2000-2019).
    Ann Allergy Asthma Immunol. 2023 Oct 15:S1081-1206(23)01315.
    PubMed     Abstract available
    
    
    
89. CHAN R, Lipworth B
    Characterising moderate-to-severe asthma patients with preserved small airway function.
    Ann Allergy Asthma Immunol. 2023 Oct 10:S1081-1206(23)01306.
    PubMed    
    
    
    
90. AVERILL SH, Forno E
    Management of the Pediatric Patient with Asthma and Obesity.
    Ann Allergy Asthma Immunol. 2023 Oct 10:S1081-1206(23)01301.
    PubMed     Abstract available
    
    
    
91. SHAKER M, Abrams EM, Sublett JW
    Corrigendum to "Contextual community epinephrine prescribing: Is more always better?" [Ann Allergy Asthma Immunol 131 (2023) 176-184].
    Ann Allergy Asthma Immunol. 2023;131:534.
    PubMed    
    
    
    
92. COSCIA G
    Asthma control questionnaires: A broader perspective.
    Ann Allergy Asthma Immunol. 2023;131:405-406.
    PubMed    
    
    
    
93. HERZBERG SD, Bosso AM, Sangal NR, Bosso JV, et al
    Eosinophilic granulomatosis with polyangiitis presenting as aspirin-exacerbated respiratory disease.
    Ann Allergy Asthma Immunol. 2023;131:528-530.
    PubMed    
    
    
    September 2023
94. BLAISS M, Oppenheimer J, Corbett M, Bacharier L, et al
    Consensus of an ACAAI, AAAAI, and ATS Workgroup on Definition of Clinical Remission in Asthma on Treatment.
    Ann Allergy Asthma Immunol. 2023 Sep 8:S1081-1206(23)01218.
    PubMed    
    
    
    
95. GRAYSON MH, Williams PV
    Defining remission in asthma care.
    Ann Allergy Asthma Immunol. 2023 Sep 7:S1081-1206(23)01217.
    PubMed    
    
    
    
96. HUNT KM, Foley M, Connors LA, Hildebrand KJ, et al
    Trends in the Proportion of Women Speakers at North American Allergy & Immunology Conferences, 2008-2020.
    Ann Allergy Asthma Immunol. 2023 Sep 7:S1081-1206(23)01215.
    PubMed     Abstract available
    
    
    
97. KIM SL, Rank MA, Peters AT
    The chronic rhinosinusitis practice parameter.
    Ann Allergy Asthma Immunol. 2023;131:307-310.
    PubMed     Abstract available
    
    
    
98. SUPRON AD, Bergmark RW, Roditi RE, Buchheit KM, et al
    Perioperative mepolizumab in aspirin-exacerbated respiratory disease does not prevent nasal polyp regrowth.
    Ann Allergy Asthma Immunol. 2023;131:384-386.
    PubMed    
    
    
    
99. RAMOS CL, Thakrar H, Walters K, Waldram J, et al
    Characterization of alcohol-induced respiratory symptoms in aspirin-exacerbated respiratory disease.
    Ann Allergy Asthma Immunol. 2023;131:382-384.
    PubMed    
    
    
    
100. MULLUR J, Buchheit KM
     Aspirin-exacerbated respiratory disease: Updates in the era of biologics.
     Ann Allergy Asthma Immunol. 2023;131:317-324.
     PubMed     Abstract available
     
     
     
101. NAEGER S, Macina D, Pool V
     Tetanus, diphtheria, and acellular pertussis vaccine coverage in adults with chronic respiratory conditions.
     Ann Allergy Asthma Immunol. 2023;131:333-337.
     PubMed     Abstract available
     
     
     August 2023
102. SCHEPEL IRM, Banzon TM, Phipatanakul W
     Future of Biologics in Pediatric Asthma: Optimizing Response, Early Introduction, and Equitable Access to Treatment.
     Ann Allergy Asthma Immunol. 2023 Aug 29:S1081-1206(23)01207.
     PubMed     Abstract available
     
     
     
103. PERSAUD PN, Tran AP, Messner D, Thornton JD, et al
     Perception of burden of oral and inhaled corticosteroid adverse effects on asthma-specific quality of life.
     Ann Allergy Asthma Immunol. 2023 Aug 27:S1081-1206(23)00636.
     PubMed     Abstract available
     
     
     
104. SCELO G, Torres-Duque CA, Maspero J, Tran TN, et al
     Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry.
     Ann Allergy Asthma Immunol. 2023 Aug 26:S1081-1206(23)00630.
     PubMed     Abstract available
     
     
     
105. GALANT SP, Morphew T
     Adding oscillometry to spirometry in guidelines better identifies uncontrolled asthma, future exacerbations, potential targeted therapy.
     Ann Allergy Asthma Immunol. 2023 Aug 23:S1081-1206(23)00587.
     PubMed     Abstract available
     
     
     
106. PAVORD ID, Hoyte FCL, Lindsley AW, Ambrose CS, et al
     Tezepelumab reduces exacerbations across all seasons in patients with severe, uncontrolled asthma (NAVIGATOR).
     Ann Allergy Asthma Immunol. 2023 Aug 22:S1081-1206(23)00593.
     PubMed     Abstract available
     
     
     
107. GAFFNEY A, Himmelstein DU, Woolhandler S
     Population-Level Trends in Asthma and COPD Emergency Department Visits and Hospitalizations Before and During the COVID-19 Pandemic in the US.
     Ann Allergy Asthma Immunol. 2023 Aug 22:S1081-1206(23)00591.
     PubMed     Abstract available
     
     
     
108. HUI-BECKMAN J, Goleva E, Leung DYM, Kim BE, et al
     The impact of temperature on the skin barrier and atopic dermatitis.
     Ann Allergy Asthma Immunol. 2023 Aug 16:S1081-1206(23)00569.
     PubMed     Abstract available
     
     
     
109. WISNIVESKY JP, Agrawal N, Ankam J, Gonzalez A, et al
     World Trade Center Workers with Asthma and PTSD More Accurately Perceive Airflow Limitation.
     Ann Allergy Asthma Immunol. 2023 Aug 12:S1081-1206(23)00568.
     PubMed     Abstract available
     
     
     
110. KAYSER MZ, Julicher BL, Welte T, Fuge J, et al
     Retrospective Analysis and Biologic Asthma Response Score reveal roadmap for switching biologics in severe asthma.
     Ann Allergy Asthma Immunol. 2023 Aug 12:S1081-1206(23)00567.
     PubMed    
     
     
     
111. AVDEEV SN, Gaynitdinova VV, Pozdnakova AA, Yu Chikina S, et al
     Asthma in elderly and COVID-19: results of 90-day post-hospital follow-up.
     Ann Allergy Asthma Immunol. 2023 Aug 7:S1081-1206(23)00564.
     PubMed    
     
     
     
112. HSU CS, Chen YM, Hsu CY, Deng YL, et al
     Diabetes Mellitus and Bone Mineral Density on Fracture Risk in Allergic Rhinitis and Asthma Patients.
     Ann Allergy Asthma Immunol. 2023 Aug 7:S1081-1206(23)00565.
     PubMed    
     
     
     
113. KOENIGSBERG R, Grayson MH
     Did the coronavirus disease 2019 pandemic change asthma prevalence?
     Ann Allergy Asthma Immunol. 2023;131:141-142.
     PubMed    
     
     
     July 2023
114. CHAN R, Lipworth B
     Real life effects of dupilumab on airway oscillometry in severe uncontrolled asthma.
     Ann Allergy Asthma Immunol. 2023 Jul 28:S1081-1206(23)00558.
     PubMed    
     
     
     
115. LEDFORD DK, Soong W, Carr W, Trevor J, et al
     Real-world Severe Asthma Biologic Administration and Adherence Differs by Biologic: CHRONICLE Study Results.
     Ann Allergy Asthma Immunol. 2023 Jul 26:S1081-1206(23)00522.
     PubMed     Abstract available
     
     
     
116. XIA T, Qiu H, Yu B, Bi J, et al
     Cost-Related Medication Nonadherence In U.S. Adults With Asthma: The National Health Interview Survey 2013-2020.
     Ann Allergy Asthma Immunol. 2023 Jul 25:S1081-1206(23)00518.
     PubMed     Abstract available
     
     
     
117. UGALDE IC, Ratigan A, Merriman C, Cui J, et al
     Preference for and Impact of Telehealth vs. In-person Asthma Visits Among Black and Latinx Adults.
     Ann Allergy Asthma Immunol. 2023 Jul 23:S1081-1206(23)00520.
     PubMed     Abstract available
     
     
     
118. CHAN R, Duraikannu C, Thouseef MJ, Lipworth B, et al
     An asthma phenotype comprising bronchial wall thickening and mucus plugging confers worse clinical outcomes.
     Ann Allergy Asthma Immunol. 2023 Jul 18:S1081-1206(23)00500.
     PubMed    
     
     
     
119. MOSNAIM G
     Can we improve adherence and asthma outcomes in children and adolescents with technology-based interventions?
     Ann Allergy Asthma Immunol. 2023 Jul 9:S1081-1206(23)00493.
     PubMed    
     
     
     
120. ZAEH SE, Chupp G, Eakin MN
     Is there a Best Strategy to Prevent Asthma Exacerbations in Inner City Asthmatics?
     Ann Allergy Asthma Immunol. 2023 Jul 9:S1081-1206(23)00492.
     PubMed    
     
     
     
121. LAU HX, Chen Z, Bever HV, Tham EH, et al
     Clinical predictors of wheeze trajectories and associations with allergy in Asian children.
     Ann Allergy Asthma Immunol. 2023 Jul 5:S1081-1206(23)00485.
     PubMed     Abstract available
     
     
     
122. SANTIAGO DVH, Fagbamigbe DAF, Sullivan PF, Agrawal DU, et al
     Intranasal steroid use and COVID-19 mortality among asthma and COPD patients: A retrospective cohort study.
     Ann Allergy Asthma Immunol. 2023 Jul 4:S1081-1206(23)00487.
     PubMed     Abstract available
     
     
     
123. BELLANTI JA, Schroer B, Marshall GD Jr, Grayson MH, et al
     The 80th anniversary of Annals of Allergy, Asthma & Immunology (1943-2023).
     Ann Allergy Asthma Immunol. 2023;131:128-130.
     PubMed     Abstract available
     
     
     
124. MENDOZA J, Carlson G, Nath P, Quinn J, et al
     A look at adherence with subcutaneous immunotherapy without out-of-pocket patient costs.
     Ann Allergy Asthma Immunol. 2023;131:96-100.
     PubMed     Abstract available
     
     
     June 2023
125. LANZ MJ, Gilbert IA, Gandhi HN, Pollack M, et al
     Patterns of rescue and maintenance therapy claims surrounding a clinical encounter for an asthma exacerbation.
     Ann Allergy Asthma Immunol. 2023 Jun 19:S1081-1206(23)00441.
     PubMed     Abstract available
     
     
     
126. LARENAS-LINNEMANN D, Romeo J, Ariue B, Oppenheimer J, et al
     ACAAI members' preferred step 1-3 asthma maintenance and reliever therapy and incomplete insurance coverage indicated as main practice hurdle.
     Ann Allergy Asthma Immunol. 2023 Jun 14:S1081-1206(23)00407.
     PubMed     Abstract available
     
     
     
127. KIM I, Morphew T, Chou C, Ehwerhemuepha L, et al
     Controller therapy attenuates asthma exacerbations associated with prior SARS-CoV-2 infection in children.
     Ann Allergy Asthma Immunol. 2023 Jun 13:S1081-1206(23)00417.
     PubMed    
     
     
     
128. LEE E, Rhee EH, Kim K, Kim HS, et al
     Frequency of exacerbation and degree of required asthma medication can characterize childhood longitudinal asthma trajectories.
     Ann Allergy Asthma Immunol. 2023 Jun 9:S1081-1206(23)00408.
     PubMed     Abstract available
     
     
     
129. NGUYEN AT, Settipane RA
     Erratum to "A potpourri of summer allergic environmental disorders" [Ann Allergy Asthma Immunol 130 (2023) 415-418].
     Ann Allergy Asthma Immunol. 2023;130:823.
     PubMed    
     
     
     May 2023
130. PHAM DD, Lee JH, Kwon HS, Song WJ, et al
     Prospective direct comparison of biological treatments on severe eosinophilic asthma: Findings from the PRISM study.
     Ann Allergy Asthma Immunol. 2023 May 31:S1081-1206(23)00402.
     PubMed     Abstract available
     
     
     
131. EKSTEDT S, Lagebro V, Georen SK, Cardell LO, et al
     Prolonged inflammatory resolution in allergic asthma relates to dysfunctional interactions between neutrophils and airway epithelium.
     Ann Allergy Asthma Immunol. 2023 May 31:S1081-1206(23)00400.
     PubMed     Abstract available
     
     
     
132. MENZIES-GOW A, Bourdin A, Chupp G, Israel E, et al
     Effect of tezepelumab on healthcare utilization in patients with severe, uncontrolled asthma: the NAVIGATOR study.
     Ann Allergy Asthma Immunol. 2023 May 30:S1081-1206(23)00399.
     PubMed     Abstract available
     
     
     
133. DEBNATH C, Agarwal S, Atkinson C, Chong LK, et al
     Impact of Race on In-Hospital Outcomes of Patients Hospitalized for Asthma Exacerbation.
     Ann Allergy Asthma Immunol. 2023 May 30:S1081-1206(23)00397.
     PubMed    
     
     
     
134. NAZARIO S, Gonzalez-Sepulveda L, Telon-Sosa B, Rivas-Tumanyan S, et al
     Place of death from asthma differs by age, race and ethnicity.
     Ann Allergy Asthma Immunol. 2023 May 22:S1081-1206(23)00359.
     PubMed    
     
     
     
135. WOO SD, Park HS, Jang JH, Lee Y, et al
     Biomarkers for Predicting Type 2-high and Uncontrolled Asthma in Real-World Practice.
     Ann Allergy Asthma Immunol. 2023 May 18:S1081-1206(23)00339.
     PubMed     Abstract available
     
     
     
136. CHAN R, Lipworth B
     Clinical impact of obesity on oscillometry lung mechanics in adult asthmatics.
     Ann Allergy Asthma Immunol. 2023 May 18:S1081-1206(23)00341.
     PubMed     Abstract available
     
     
     
137. BEDOLLA-BARAJAS M, Morales-Romero J, Robles-Figueroa M, Delgado-Figueroa T, et al
     Changes in the national prevalence of asthma and COVID-19 fatality: A population-based cross-sectional study.
     Ann Allergy Asthma Immunol. 2023 May 2:S1081-1206(23)00327.
     PubMed     Abstract available
     
     
     
138. HANTGAN SL, Jariwala SP
     Erratum to "User-centered mobile health applications for asthma" [Ann Allergy Asthma Immunol 130 (2023) 159-160].
     Ann Allergy Asthma Immunol. 2023;130:692.
     PubMed    
     
     
     
139. GOLDSOBEL AB
     Corrigendum to "Chronic cough comes of age" [Ann Allergy Asthma Immunol 130 (2023) Pages 4-5].
     Ann Allergy Asthma Immunol. 2023;130:692.
     PubMed    
     
     
     
140. GALANT SP
     Could salivary alpha-amylase be a proxy for identifying beta-2 adrenergic induced tolerization in asthma?
     Ann Allergy Asthma Immunol. 2023;130:544-545.
     PubMed    
     
     
     
141. STROTHMAN K
     Choosing biologics for uncontrolled asthma: A conundrum for clinicians.
     Ann Allergy Asthma Immunol. 2023;130:534-535.
     PubMed    
     
     
     April 2023
142. LUCAS D, Gourier G, Bygvraa DA, Canals ML, et al
     Occupational allergic diseases among harvesting fishermen at the open sea: a systematic review.
     Ann Allergy Asthma Immunol. 2023 Apr 26:S1081-1206(23)00285.
     PubMed     Abstract available
     
     
     
143. CHIPPS B, Zeiger RS, Beuther DA, Reibman J, et al
     The Asthma Impairment and Risk Questionnaire Enhances the Assessment of Asthma Control.
     Ann Allergy Asthma Immunol. 2023 Apr 25:S1081-1206(23)00308.
     PubMed     Abstract available
     
     
     
144. SHEEHAN WJ, Maghzian N, Rastogi D, Bollard CM, et al
     Decreased Regulatory B Cells in Pediatric Patients with Asthma.
     Ann Allergy Asthma Immunol. 2023 Apr 24:S1081-1206(23)00306.
     PubMed    
     
     
     
145. ITO K, Kanemitsu Y, Fukumitsu K, Tajiri T, et al
     Targeting the IL-5 pathway improves cough hypersensitivity in patients with severe uncontrolled asthma.
     Ann Allergy Asthma Immunol. 2023 Apr 24:S1081-1206(23)00310.
     PubMed     Abstract available
     
     
     
146. LEE JH, Hong C, Oh JS, Kim TB, et al
     Electronic Medical Record-Based Machine Learning Predicts the Relapse of Asthma Exacerbation.
     Ann Allergy Asthma Immunol. 2023 Apr 24:S1081-1206(23)00307.
     PubMed    
     
     
     
147. HONG B, Merrill KA, Golding MA, Simons E, et al
     Pre-hospital epinephrine administration for treating anaphylaxis among those with co-morbid asthma: A scoping review.
     Ann Allergy Asthma Immunol. 2023 Apr 21:S1081-1206(23)00267.
     PubMed     Abstract available
     
     
     
148. SHANNON CM, Flaherty C, Quarshie WO, Xiao R, et al
     Asthma medication adherence during the COVID-19 pandemic in children at high risk of exacerbation.
     Ann Allergy Asthma Immunol. 2023 Apr 18:S1081-1206(23)00263.
     PubMed    
     
     
     
149. FUKUMITSU K, Kanemitsu Y, Kurokawa R, Takeda N, et al
     Tiotropium for refractory cough in asthma via cough reflex sensitivity: a randomized, parallel, open-label, trial.
     Ann Allergy Asthma Immunol. 2023 Apr 6:S1081-1206(23)00248.
     PubMed     Abstract available
     
     
     
150. TEAGUE WG
     Analysis of lung lavage granulocyte constituents and blood type 2 biomarkers does not support routine use of corticosteroids in children with problematic wheeze: Reply to: Short courses of oral corticosteroids are effective, important, and safe for vi
     Ann Allergy Asthma Immunol. 2023;130:526.
     PubMed    
     
     
     
151. WEINBERGER M
     Short courses of oral corticosteroids are effective, important, and safe for virus-triggered wheeze.
     Ann Allergy Asthma Immunol. 2023;130:525.
     PubMed    
     
     
     March 2023
152. LEE E, Park YM, Lee SY, Lee SH, et al
     Associations of prenatal antibiotic exposure and delivery mode on childhood asthma inception.
     Ann Allergy Asthma Immunol. 2023 Mar 27:S1081-1206(23)00208.
     PubMed     Abstract available
     
     
     
153. REDDY A, Dunivin G, Garlapati R, Reddy S, et al
     Readability and quality of patient education material for asthma.
     Ann Allergy Asthma Immunol. 2023 Mar 27:S1081-1206(23)00209.
     PubMed    
     
     
     
154. ALI H, Douwes J, Burmanje J, Gokhale P, et al
     Sputum inflammatory, neural, and remodelling mediators in eosinophilic and non-eosinophilic asthma.
     Ann Allergy Asthma Immunol. 2023 Mar 21:S1081-1206(23)00181.
     PubMed     Abstract available
     
     
     
155. JACKSON DJ, Bacharier LB, Phipatanakul W, Sher L, et al
     Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma.
     Ann Allergy Asthma Immunol. 2023 Mar 21:S1081-1206(23)00180.
     PubMed     Abstract available
     
     
     
156. HORN A, Bernstein DI, Okubo K, Dalgaard T, et al
     House Dust Mite Sublingual Immunotherapy Tablet Safety in Adolescents with Allergic Rhinoconjunctivitis: Clinical Trial Results.
     Ann Allergy Asthma Immunol. 2023 Mar 14:S1081-1206(23)00171.
     PubMed     Abstract available
     
     
     
157. CHIPPS BE, Soong W, Panettieri RA Jr, Carr W, et al
     Number of patient-reported asthma triggers predicts uncontrolled disease among specialist-treated patients with severe asthma.
     Ann Allergy Asthma Immunol. 2023 Mar 9:S1081-1206(23)00165.
     PubMed     Abstract available
     
     
     
158. GUTWEIN A, Han YY, Colon-Semidey A, Alvarez M, et al
     Low parental numeracy and severe asthma exacerbations in a prospective study of Puerto Rican youth.
     Ann Allergy Asthma Immunol. 2023 Mar 7:S1081-1206(23)00166.
     PubMed     Abstract available
     
     
     
159. VOLERMAN A, Balachandran U, Zhu M, Akel M, et al
     Evaluating Inhaler Education Interventions for Hospitalized Children with Asthma: A Randomized Controlled Trial.
     Ann Allergy Asthma Immunol. 2023 Mar 2:S1081-1206(23)00131.
     PubMed     Abstract available
     
     
     
160. ACEVES SS, Dellon ES, Greenhawt M, Hirano I, et al
     Clinical guidance for the use of dupilumab in eosinophilic esophagitis: A yardstick.
     Ann Allergy Asthma Immunol. 2023;130:371-378.
     PubMed     Abstract available
     
     
     February 2023
161. CHAN R, Lipworth B
     Efficacy of biologic therapy on airway hyperresponsiveness in asthma.
     Ann Allergy Asthma Immunol. 2023 Feb 23:S1081-1206(23)00121.
     PubMed     Abstract available
     
     
     
162. LEDFORD DK
     Self-Contained Underwater Breathing Apparatus (SCUBA) Diving and Asthma: Where are we in 2023?
     Ann Allergy Asthma Immunol. 2023 Feb 17:S1081-1206(23)00046.
     PubMed     Abstract available
     
     
     
163. STICKLER MB, Hamilton RG, Cooke RK, Bollinger ME, et al
     An emerging new respiratory pathogen, Lophomonas blattarum, found in bronchoalveolar lavage in an immunodeficient patient with asthma.
     Ann Allergy Asthma Immunol. 2023 Feb 13:S1081-1206(23)00091.
     PubMed    
     
     
     
164. KAMAN K, Dhodapkar M, Shabanova V, McCollum S, et al
     Validated Anxiety Assessments Among Pediatric Peanut-Allergic Patients on Oral Immunotherapy.
     Ann Allergy Asthma Immunol. 2023 Feb 2:S1081-1206(23)00080.
     PubMed     Abstract available
     
     
     
165. PANDYA A, Portnoy J
     Does improved indoor air quality lead to better asthma control?
     Ann Allergy Asthma Immunol. 2023;130:147-148.
     PubMed    
     
     
     
166. BORISH L, Teague WG, Patrie JT, Wavell KW, et al
     Further evidence of a type 2 inflammatory signature in chronic obstructive pulmonary disease or emphysema.
     Ann Allergy Asthma Immunol. 2023 Feb 1:S1081-1206(23)00078.
     PubMed     Abstract available
     
     
     January 2023
167. HOLLENBACH JP, Collins MS, Wasser C, Fedele D, et al
     Implementation of standardized asthma management programs in outpatient settings.
     Ann Allergy Asthma Immunol. 2023 Jan 23:S1081-1206(23)00041.
     PubMed     Abstract available
     
     
     
168. OPPENHEIMER J, Borish L
     Operationalization of Dynamic Dosing in Asthma.
     Ann Allergy Asthma Immunol. 2023 Jan 17:S1081-1206(23)00008.
     PubMed    
     
     
     
169. SUZUKAWA M, Ohta K, Hashimoto H, Oyamada Y, et al
     Characterization and cluster analyses of elderly asthma in comparison with non-elderly asthma patients in Japan.
     Ann Allergy Asthma Immunol. 2023 Jan 16:S1081-1206(23)00005.
     PubMed     Abstract available
     
     
     
170. GALANT SP, Morphew T
     IN YOUNG ASTHMATIC CHILDREN, OBESITY AND UNCONTROLLED DISEASE ARE HIGHLY ASSOCIATED WITH PERIPHERAL AIRWAY IMPAIRMENT.
     Ann Allergy Asthma Immunol. 2023 Jan 13:S1081-1206(23)00004.
     PubMed     Abstract available
     
     
     
171. GOLDSOBEL AB
     Chronic cough comes of age.
     Ann Allergy Asthma Immunol. 2023;130:4-5.
     PubMed    
     
     
     
172. NEAVES BI, Adams KE, White KM, Stokes SC, et al
     Long-term adherence to imported fire ant subcutaneous immunotherapy.
     Ann Allergy Asthma Immunol. 2023;130:106-110.
     PubMed     Abstract available
     
     
     December 2022
173. PITRE T, Jassal T, Angjeli A, Jarabana V, et al
     A comparison of the effectiveness of biologic therapies for asthma:a systematic review and network meta-analysis.
     Ann Allergy Asthma Immunol. 2022 Dec 20:S1081-1206(22)02000.
     PubMed     Abstract available
     
     
     
174. CORBETT M, Allen A, Bobo N, Foggs MB, et al
     Proceedings of a Roundtable Conducted by the American College of Allergy, Asthma & Immunology on Racial Disparities in Atopic Dermatitis and Food Allergy.
     Ann Allergy Asthma Immunol. 2022 Dec 17:S1081-1206(22)02001.
     PubMed     Abstract available
     
     
     
175. CHEN JH, Orden T, Wang J, Sowho M, et al
     Risk of anaphylaxis in cluster versus standard subcutaneous multi-allergen immunotherapy.
     Ann Allergy Asthma Immunol. 2022 Dec 12:S1081-1206(22)01993.
     PubMed     Abstract available
     
     
     
176. CHAN R, Lipworth B
     Severe asthma with fungal sensitisation is associated with worse small airways dysfunction but similar symptom control.
     Ann Allergy Asthma Immunol. 2022 Dec 10:S1081-1206(22)01987.
     PubMed    
     
     
     
177. SHER LD, Passalacqua G, Taille C, Cohn L, et al
     Long-term effect of dupilumab on dyspnea, sleep, and activity in oral corticosteroid-dependent severe asthma.
     Ann Allergy Asthma Immunol. 2022 Dec 9:S1081-1206(22)01983.
     PubMed     Abstract available
     
     
     
178. INSELMAN JW, Jeffery MM, Maddux JT, Lam RW, et al
     A prediction model for asthma exacerbations after stopping asthma biologics.
     Ann Allergy Asthma Immunol. 2022 Dec 9:S1081-1206(22)01972.
     PubMed     Abstract available
     
     
     
179. CHAN R, Duraikannu C, Lipworth B
     Clinical characteristics of the asthma bronchiectasis phenotype.
     Ann Allergy Asthma Immunol. 2022 Dec 8:S1081-1206(22)01984.
     PubMed    
     
     
     
180. MAKIN T, Breidenbaugh M, Borish L
     Novel insights into pathogenic mechanisms of severe exacerbation-prone asthma and their impact on clinical management.
     Ann Allergy Asthma Immunol. 2022;129:651-652.
     PubMed    
     
     
     
181. GRAYSON MH
     Announcing the 2022 American College of Allergy, Asthma and Immunology Annals fellow-in-training award winners.
     Ann Allergy Asthma Immunol. 2022;129:649-650.
     PubMed    
     
     
     
182. TEAGUE WG
     Lung lavage inflammatory patterns and pathogen profiles in preschool children with problematic wheeze.
     Ann Allergy Asthma Immunol. 2022;129:674-675.
     PubMed    
     
     
     November 2022
183. KHAN DA
     The best of 2022 American College of Allergy, Asthma, and Immunology literature review.
     Ann Allergy Asthma Immunol. 2022 Nov 29:S1081-1206(22)01901.
     PubMed    
     
     
     
184. LI C, Zhang B, Yan M, Li Y, et al
     Cluster Analysis of Patients with Chronic Rhinosinusitis and Asthma after Endoscopic Sinus Surgery.
     Ann Allergy Asthma Immunol. 2022 Nov 24:S1081-1206(22)01955.
     PubMed     Abstract available
     
     
     
185. RIEDL MA
     Update on skin diseases: Urticaria, angioedema, and other skin disorders from the 2022 American College of Allergy, Asthma, and Immunology Annual Literature Review.
     Ann Allergy Asthma Immunol. 2022 Nov 23:S1081-1206(22)01913.
     PubMed    
     
     
     
186. HANTGAN SL, Jariwala SP
     User-centered mobile health applications for asthma.
     Ann Allergy Asthma Immunol. 2022 Nov 15. pii: S1081-1206(22)01917.
     PubMed    
     
     
     
187. ZHANG X, Xu Z, Lin J, Xie G, et al
     Sex differences of small airway function and FeNO in patients with mild asthma.
     Ann Allergy Asthma Immunol. 2022 Nov 15. pii: S1081-1206(22)01916.
     PubMed     Abstract available
     
     
     
188. BERGER P, Menzies-Gow A, Peters AT, Kuna P, et al
     Long-term efficacy of dupilumab in asthma with and without chronic rhinosinusitis and/or nasal polyps.
     Ann Allergy Asthma Immunol. 2022 Nov 7. pii: S1081-1206(22)01912.
     PubMed     Abstract available
     
     
     
189. GREINER B, Cronin K, Salazar L, Hartwell M, et al
     Asthma related disparities in emergency department usage and clinical outcomes among Spanish speaking Hispanic patients.
     Ann Allergy Asthma Immunol. 2022 Nov 7. pii: S1081-1206(22)01909.
     PubMed    
     
     
     
190. HANANIA NA, Castro M, Bateman E, Pavord ID, et al
     Efficacy of Dupilumab in Patients with Moderate-to-Severe Asthma and Persistent Airflow Obstruction.
     Ann Allergy Asthma Immunol. 2022 Nov 1. pii: S1081-1206(22)01899.
     PubMed     Abstract available
     
     
     
191. GHIASI Y, Wangberg H, Bagsic SRS, White A, et al
     Type 2 biologics reduce cumulative steroid exposure in aspirin-exacerbated respiratory disease.
     Ann Allergy Asthma Immunol. 2022;129:642-643.
     PubMed    
     
     
     October 2022
192. FONG WCG, Kadalayil L, Lowther S, Grevatt S, et al
     Efficacy of Dyson air purifier on asthma control: a single-center, investigator-led, randomized, double-blind, placebo-controlled trial.
     Ann Allergy Asthma Immunol. 2022 Oct 23. pii: S1081-1206(22)01850.
     PubMed     Abstract available
     
     
     
193. MCCULLOCH MR, Thomas JF, Thompson MA, Carel KD, et al
     Outpatient Electronic Consultations in Pediatric Allergy/Immunology.
     Ann Allergy Asthma Immunol. 2022 Oct 8. pii: S1081-1206(22)01827.
     PubMed    
     
     
     
194. LI JT
     Asthma chronic obstructive pulmonary disease and lower respiratory disorders.
     Ann Allergy Asthma Immunol. 2022 Oct 6:S1081-1206(22)01727.
     PubMed    
     
     
     
195. WEINBERGER M
     Can current hospitalization rates for asthma be decreased?
     Ann Allergy Asthma Immunol. 2022;129:401-402.
     PubMed    
     
     
     
196. WEINBERGER M
     Should asthma evaluation include assessment of small airway function?
     Ann Allergy Asthma Immunol. 2022;129:399-400.
     PubMed    
     
     
     
197. COLAK Y, Ingebrigtsen TS, Nordestgaard BG, Marott JL, et al
     Plasma immunoglobulin E and risk of exacerbation and mortality in chronic obstructive pulmonary disease: A contemporary population-based cohort.
     Ann Allergy Asthma Immunol. 2022;129:490-496.
     PubMed     Abstract available
     
     
     September 2022
198. CHAN R, Stewart K, Lipworth B
     Airflow obstruction in real life is associated with small airways dysfunction in moderate to severe asthma.
     Ann Allergy Asthma Immunol. 2022 Sep 24. pii: S1081-1206(22)01775.
     PubMed    
     
     
     
199. SANGKANJANAVANICH S, Pradubpongsa P, Mitthamsiri W, Sangasapaviliya A, et al
     Bifidobacterium infantis 35624 Efficacy in Patients with Uncontrolled Asthma: A Randomized Placebo-Controlled Trial.
     Ann Allergy Asthma Immunol. 2022 Sep 8. pii: S1081-1206(22)01712.
     PubMed    
     
     
     August 2022
200. BIGGS SE, Ownby DR, May KR
     Use of over-the-counter inhaled epinephrine in asthma.
     Ann Allergy Asthma Immunol. 2022 Aug 27. pii: S1081-1206(22)01674.
     PubMed    
     
     
     
201. PRICE AS, Kennedy JL
     T helper 2 Mechanisms involved in Human Rhinovirus Infections and Asthma.
     Ann Allergy Asthma Immunol. 2022 Aug 21. pii: S1081-1206(22)00695.
     PubMed     Abstract available
     
     
     
202. LIU J, Yuan MB, Chen YQ, Wang Y, et al
     Global burden of asthma associated with high body mass index from 1990 to 2019.
     Ann Allergy Asthma Immunol. 2022 Aug 21. pii: S1081-1206(22)00694.
     PubMed     Abstract available
     
     
     
203. CHOW TG, Palka JM, Stone B, Trojan T, et al
     Safety of Subcutaneous Immunotherapy in Patients with Severe Asthma.
     Ann Allergy Asthma Immunol. 2022 Aug 20. pii: S1081-1206(22)00693.
     PubMed     Abstract available
     
     
     
204. COLETTA C, Grayson MH
     Causation or coincidence? Phenotype of asthma exacerbations during the coronavirus disease 2019 pandemic.
     Ann Allergy Asthma Immunol. 2022;129:131-132.
     PubMed    
     
     
     July 2022
205. BRYANT N, Muehling LM
     T-cell responses in asthma exacerbations.
     Ann Allergy Asthma Immunol. 2022 Jul 30. pii: S1081-1206(22)00621.
     PubMed     Abstract available
     
     
     
206. IMAM SF, Zafar S, Oppenheimer J
     SMART in treatment of asthma exacerbations.
     Ann Allergy Asthma Immunol. 2022 Jul 29. pii: S1081-1206(22)00619.
     PubMed     Abstract available
     
     
     
207. GREINER B, Hartwell M
     Prevalence and associations between metabolically unhealthy obesity and asthma exacerbations and emergency department usage.
     Ann Allergy Asthma Immunol. 2022 Jul 14. pii: S1081-1206(22)00590.
     PubMed     Abstract available
     
     
     
208. PATE CA, Zahran HS, Malilay J, Hsu J, et al
     The Shifting Prevalence of Asthma and Allergic Disease in United States Children.
     Ann Allergy Asthma Immunol. 2022 Jul 13. pii: S1081-1206(22)00586.
     PubMed     Abstract available
     
     
     June 2022
209. LEE TY, Petkau J, Mangat N, Safari A, et al
     16-year trends in asthma hospital admissions in Canada.
     Ann Allergy Asthma Immunol. 2022 Jun 29. pii: S1081-1206(22)00540.
     PubMed     Abstract available
     
     
     
210. DINWIDDIE DL, Kaukis N, Pham S, Hardin O, et al
     Viral infection and allergy status impact severity of asthma symptoms in children with asthma exacerbations.
     Ann Allergy Asthma Immunol. 2022 Jun 21. pii: S1081-1206(22)00535.
     PubMed     Abstract available
     
     
     
211. PANETTIERI RA JR, Ledford DK, Chipps BE, Soong W, et al
     Biologic Use and Outcomes Among Adults with Severe Asthma Treated by United States Subspecialists.
     Ann Allergy Asthma Immunol. 2022 Jun 18. pii: S1081-1206(22)00532.
     PubMed     Abstract available
     
     
     
212. POLIVKA BJ, Huntington-Moskos L, Antimisiaris DE, Cavallazzi RS, et al
     Phenotyping Older Adults with Asthma via Cluster Analysis.
     Ann Allergy Asthma Immunol. 2022 Jun 10. pii: S1081-1206(22)00501.
     PubMed    
     
     
     
213. RURAN HB, Maciag MC, Murphy SE, Phipatanakul W, et al
     Cross-Sectional Study of Urinary Biomarkers of Environmental Tobacco and E-Cigarette Exposure and Asthma Morbidity.
     Ann Allergy Asthma Immunol. 2022 Jun 7. pii: S1081-1206(22)00499.
     PubMed    
     
     
     
214. BELLANTI JA, Lanier BQ, Ein D, Finegold I, et al
     The American College of Allergy, Asthma & Immunology: an 80-year legacy of accomplishments (1942-2022), part 3: events and achievements (2012-2022).
     Ann Allergy Asthma Immunol. 2022 Jun 4. pii: S1081-1206(22)00494.
     PubMed    
     
     
     
215. CHUNG Y, Katial R, Mu F, Cook EE, et al
     Real-world effectiveness of benralizumab: Results from the ZEPHYR 1 Study.
     Ann Allergy Asthma Immunol. 2022;128:669-676.
     PubMed     Abstract available
     
     
     May 2022
216. SCIOSCIA BG, Lacedonia D, Quarato CMI, Tondo P, et al
     Could Transthoracic Ultrasound be useful to suggest a small airways disease in severe uncontrolled asthma?
     Ann Allergy Asthma Immunol. 2022 May 25. pii: S1081-1206(22)00491.
     PubMed     Abstract available
     
     
     
217. CHUPP G, Wechsler ME
     Biologic Medications in Asthma: What have we learned from long-term studies?
     Ann Allergy Asthma Immunol. 2022 May 24. pii: S1081-1206(22)00489.
     PubMed    
     
     
     
218. WANG EA, Goleva E, Ketosugbo K, Kern JA, et al
     Effect of immune checkpoint inhibitors on asthma.
     Ann Allergy Asthma Immunol. 2022 May 24. pii: S1081-1206(22)00487.
     PubMed    
     
     
     
219. LIPWORTH DB, Stewart MK, Chan DR
     Pragmatic reappraisal of long acting muscarinic antagonists at steps 4/5 for persistent adult asthma: Invited Perspective article for Annals of Allergy, Asthma and Immunology.
     Ann Allergy Asthma Immunol. 2022 May 22. pii: S1081-1206(22)00449.
     PubMed    
     
     
     
220. HUDDLESTON CM, Slaven JE, Weist AD, Krupp NL, et al
     Increased Healthcare Utilization in Moderate to Severe Asthma Patients Due to Frequent Preferred Medication Changes.
     Ann Allergy Asthma Immunol. 2022 May 21. pii: S1081-1206(22)00448.
     PubMed    
     
     
     
221. SHERREY J, Biggs S, Dorrian J, Martin J, et al
     Allergic disease, sleep problems and psychological distress in children recruited from the general community.
     Ann Allergy Asthma Immunol. 2022 May 19. pii: S1081-1206(22)00409.
     PubMed     Abstract available
     
     
     
222. MENDY A, Mersha TB
     Comorbidities in Childhood-onset and Adult-Onset Asthma.
     Ann Allergy Asthma Immunol. 2022 May 17. pii: S1081-1206(22)00410.
     PubMed     Abstract available
     
     
     
223. POLINSKI KJ, Bell GA, Trinh MH, Sundaram R, et al
     Maternal obesity, gestational weight gain and offspring asthma and atopy.
     Ann Allergy Asthma Immunol. 2022 May 9. pii: S1081-1206(22)00397.
     PubMed     Abstract available
     
     
     
224. WILSON K, Gebretsadik T, Adgent MA, Loftus C, et al
     The association between duration of breastfeeding and childhood asthma outcomes.
     Ann Allergy Asthma Immunol. 2022 May 9. pii: S1081-1206(22)00400.
     PubMed     Abstract available
     
     
     
225. YAMANE M, Ohnishi H, Tsuji K, Anabuki K, et al
     Dupilumab-induced peripheral neuropathy in a patient with severe asthma.
     Ann Allergy Asthma Immunol. 2022;128:611.
     PubMed    
     
     
     
226. GALANT SP, Morphew T, Ehwerhemuepha L
     Reduced exposure to respiratory viral triggers may explain less health care utilization for children with asthma.
     Ann Allergy Asthma Immunol. 2022;128:486-487.
     PubMed    
     
     
     
227. WHITE AA
     If aspirin-exacerbated respiratory disease treatment is a jigsaw puzzle, where do the aspirin and biologic pieces go?
     Ann Allergy Asthma Immunol. 2022;128:484-485.
     PubMed    
     
     
     
228. GRAYSON MH
     New! American College of Allergy, Asthma and Immunology Annals fellow-in-training award program.
     Ann Allergy Asthma Immunol. 2022;128:483.
     PubMed    
     
     
     
229. SPERGEL BL, Ruffner MA, Godwin BC, Liacouras CA, et al
     Improvement in eosinophilic esophagitis when using dupilumab for other indications or compassionate use.
     Ann Allergy Asthma Immunol. 2022;128:589-593.
     PubMed     Abstract available
     
     
     April 2022
230. HASAN ARSHAD S
     Does allergen Immunotherapy for allergic rhinitis prevent asthma?
     Ann Allergy Asthma Immunol. 2022 Apr 29. pii: S1081-1206(22)00392.
     PubMed     Abstract available
     
     
     
231. WONG M, Forno E, Celedon JC
     Asthma: interactions between obesity and other risk factors.
     Ann Allergy Asthma Immunol. 2022 Apr 29. pii: S1081-1206(22)00394.
     PubMed     Abstract available
     
     
     
232. NIESSEN NM, Fricker M, McDonald VM, Gibson PG, et al
     T2-low: What do we know? - Past, present, and future of biologic therapies in non-eosinophilic asthma.
     Ann Allergy Asthma Immunol. 2022 Apr 26. pii: S1081-1206(22)00342.
     PubMed     Abstract available
     
     
     
233. CIPRANDI G, Schiavetti I, Cioffi L, Pane M, et al
     The PRObiotics in Pediatric Asthma Management (PROPAM) study: a post-hoc analysis in allergic children.
     Ann Allergy Asthma Immunol. 2022 Apr 26. pii: S1081-1206(22)00391.
     PubMed    
     
     
     
234. ELDEIRAWI KM, Nyenhuis SM, Huntington-Moskos L, Polivka BJ, et al
     COVID-19 Related Anxiety Is Associated with Uncontrolled Asthma in Adults.
     Ann Allergy Asthma Immunol. 2022 Apr 22. pii: S1081-1206(22)00308.
     PubMed    
     
     
     
235. WINSLOW A, Keet C
     Preventing Allergies Through the Skin.
     Ann Allergy Asthma Immunol. 2022 Apr 22. pii: S1081-1206(22)00311.
     PubMed     Abstract available
     
     
     
236. ZHANG H, Xian M, Shi X, Luo T, et al
     Blocking function of allergen-specific IgG, F(ab')2, and Fab antibodies prepared from patients undergoing Dermatophagoides pteronyssinus immunotherapy.
     Ann Allergy Asthma Immunol. 2022 Apr 8. pii: S1081-1206(22)00293.
     PubMed     Abstract available
     
     
     
237. ALABDULKARIM N, Gai J, Bost J, Pillai D, et al
     Effect of the COVID-19 pandemic on morbidity among children hospitalized for an asthma exacerbation.
     Ann Allergy Asthma Immunol. 2022 Apr 7. pii: S1081-1206(22)00294.
     PubMed     Abstract available
     
     
     
238. CROPPER KJ, Davis BE, Cockcroft DW
     Effect of daily tiotropium on allergen-induced early asthmatic responses and airway inflammation.
     Ann Allergy Asthma Immunol. 2022 Apr 5. pii: S1081-1206(22)00296.
     PubMed    
     
     
     
239. OPPENHEIMER J, Leung DYM
     Asthma 2022-moving toward precision medicine.
     Ann Allergy Asthma Immunol. 2022;128:343.
     PubMed    
     
     
     
240. BORISH L
     Rethinking the central role of mast cells in virally-mediated asthma exacerbations.
     Ann Allergy Asthma Immunol. 2022 Apr 1. pii: S1081-1206(22)00288.
     PubMed    
     
     
     
241. MISS OZUNA L, Ryan T, Bensko JC, Laidlaw TM, et al
     Dupilumab-associated arthralgia in patients with aspirin-exacerbated respiratory disease.
     Ann Allergy Asthma Immunol. 2022;128:469-472.
     PubMed    
     
     
     March 2022
242. HOWELL D, Rogers L, Kasarskis A, Twyman K, et al
     Comparison and Validation of Algorithms for Asthma Diagnosis in an Electronic Medical Record System.
     Ann Allergy Asthma Immunol. 2022 Mar 30. pii: S1081-1206(22)00285.
     PubMed     Abstract available
     
     
     
243. MACDONALD M, Chang WC, Martin LJ, Hershey GKK, et al
     The Pediatric Asthma Risk Score (PARS): more does not mean better.
     Ann Allergy Asthma Immunol. 2022 Mar 29. pii: S1081-1206(22)00284.
     PubMed    
     
     
     
244. KIMURA H, Shimizu K, Tanabe N, Makita H, et al
     Further evidence for association of YKL-40 with severe asthma airway remodeling.
     Ann Allergy Asthma Immunol. 2022 Mar 24. pii: S1081-1206(22)00207.
     PubMed     Abstract available
     
     
     
245. LUDWIG A, Brehm C, Fung C, Jia S, et al
     Asthma and COVID-19 related outcomes in hospitalized patients: A single center experience.
     Ann Allergy Asthma Immunol. 2022 Mar 24. pii: S1081-1206(22)00208.
     PubMed     Abstract available
     
     
     
246. OPPENHEIMER J, Hoyte FCL, Phipatanakul W, Silver J, et al
     Allergic and eosinophilic asthma in the era of biomarkers and biologics: similarities, differences and misconceptions.
     Ann Allergy Asthma Immunol. 2022 Mar 7. pii: S1081-1206(22)00170.
     PubMed     Abstract available
     
     
     
247. ADEJUMO I, Patel M, McKeever TM, Shaw DE, et al
     Does inhaler technology improve adherence and asthma control? A pilot randomised controlled trial.
     Ann Allergy Asthma Immunol. 2022 Mar 4. pii: S1081-1206(22)00169.
     PubMed    
     
     
     
248. WANG Y, Guo D, Chen X, Wang S, et al
     Trends in asthma among adults in the United States, NHANES 2005-2018.
     Ann Allergy Asthma Immunol. 2022 Mar 4. pii: S1081-1206(22)00168.
     PubMed    
     
     
     
249. PATEL P, Bensko JC, Bhattacharyya N, Laidlaw TM, et al
     Dupilumab as an adjunct to surgery in patients with aspirin-exacerbated respiratory disease.
     Ann Allergy Asthma Immunol. 2022;128:326-328.
     PubMed    
     
     
     February 2022
250. KOINIS-MITCHELL D, D'Angelo C, Dunsiger S, McQuaid E, et al
     Effects of COVID-19 Pandemic on Children, Adolescents and Young Adults with Asthma in Rhode Island: Patterns in Emergency Department Utilization with Geospatial Mapping.
     Ann Allergy Asthma Immunol. 2022 Feb 25. pii: S1081-1206(22)00120.
     PubMed     Abstract available
     
     
     
251. MACIAG MC, Phipatanakul W
     Update on Indoor Allergens and Their Impact on Pediatric Asthma.
     Ann Allergy Asthma Immunol. 2022 Feb 25. pii: S1081-1206(22)00119.
     PubMed     Abstract available
     
     
     
252. RAMEY OL, Silva Almodovar A, Nahata MC
     Medication Adherence in Medicare Enrolled Older Adults with Asthma Before and During the COVID-19 Pandemic.
     Ann Allergy Asthma Immunol. 2022 Feb 25. pii: S1081-1206(22)00121.
     PubMed     Abstract available
     
     
     
253. MELHORN DJ, Howell DI, Pavord PID
     Should we apply a treatable traits approach to asthma care?
     Ann Allergy Asthma Immunol. 2022 Feb 13. pii: S1081-1206(22)00098.
     PubMed     Abstract available
     
     
     
254. SEHAYEK D, Gold MS, Gabrielli S, Abrams EM, et al
     Seafood-Induced Anaphylaxis in Children Presenting to Canadian Emergency Departments: Rates, Clinical Presentation and Management.
     Ann Allergy Asthma Immunol. 2022 Feb 13. pii: S1081-1206(22)00097.
     PubMed     Abstract available
     
     
     
255. ENG V, Moreno GP, Chang J, Liebhaber M, et al
     A Pediatric Asthma Camp Experience during the COVID-19 Pandemic.
     Ann Allergy Asthma Immunol. 2022 Feb 4. pii: S1081-1206(22)00087.
     PubMed    
     
     
     
256. MULLUR J, Steger CM, Gakpo D, Bensko JC, et al
     Aspirin desensitization and biologics in aspirin-exacerbated respiratory disease: Efficacy, tolerability, and patient experience.
     Ann Allergy Asthma Immunol. 2022 Feb 4. pii: S1081-1206(22)00090.
     PubMed     Abstract available
     
     
     
257. CHIPPS BE, Murphy KR, Wise RA, McCann WA, et al
     Assessing Construct Validity of the Asthma Impairment and Risk Questionnaire Using a 3-month Exacerbation Recall.
     Ann Allergy Asthma Immunol. 2022 Feb 2. pii: S1081-1206(22)00081.
     PubMed     Abstract available
     
     
     
258. GUILBERT TW, Biagini JM, Ramsey RR, Keidel K, et al
     Treatment by Biomarker-Informed Endotype Versus Guideline Care in Children with Difficult to Treat Asthma.
     Ann Allergy Asthma Immunol. 2022 Feb 2. pii: S1081-1206(22)00076.
     PubMed    
     
     
     January 2022
259. STOUT S, Murphy H, Pandya A, Yeh HW, et al
     The Effect of COVID-19 on Asthma Visits.
     Ann Allergy Asthma Immunol. 2022 Jan 28. pii: S1081-1206(22)00048.
     PubMed    
     
     
     
260. GENG B, Dixon AE, Ko J, Janampally P, et al
     Impact of body mass index on omalizumab response in adults with moderate-to-severe allergic asthma.
     Ann Allergy Asthma Immunol. 2022 Jan 28. pii: S1081-1206(22)00045.
     PubMed     Abstract available
     
     
     
261. WANG E, Wechsler ME
     A Rational Approach to Compare and Select Biologic Therapeutics in Asthma.
     Ann Allergy Asthma Immunol. 2022 Jan 27. pii: S1081-1206(22)00046.
     PubMed     Abstract available
     
     
     
262. POPOV TA, Hristova D, Kralimarkova TZ, Mustakov TB, et al
     Time course of disease characteristics in subjects with severe allergic asthma starting treatment with omalizumab.
     Ann Allergy Asthma Immunol. 2022 Jan 24. pii: S1081-1206(22)00024.
     PubMed    
     
     
     
263. DROUIN O, Smyrnova A, Betinjane N, Ducharme FM, et al
     Adherence to inhaled corticosteroids prescribed once- vs twice-daily in children with asthma.
     Ann Allergy Asthma Immunol. 2022 Jan 22. pii: S1081-1206(22)00022.
     PubMed     Abstract available
     
     
     
264. MUISER S, Gosens R, van den Berge M, Kerstjens HAM, et al
     Understanding the role of long-acting muscarinic antagonists in asthma treatment.
     Ann Allergy Asthma Immunol. 2022 Jan 21. pii: S1081-1206(22)00017.
     PubMed     Abstract available
     
     
     
265. ESCHENBACHER W, Kim M, Mattos J, Lawrence M, et al
     Activation of platelet-adherent basophils in chronic rhinosinusitis with alcohol hypersensitivity.
     Ann Allergy Asthma Immunol. 2022 Jan 18. pii: S1081-1206(22)00014.
     PubMed     Abstract available
     
     
     
266. FENG X, Lawrence MG, Payne SC, Mattos J, et al
     Lower viral loads in rhinovirus-challenged allergic subjects despite reduced innate immunity.
     Ann Allergy Asthma Immunol. 2022 Jan 12. pii: S1081-1206(22)00010.
     PubMed     Abstract available
     
     
     
267. VISWAM D, Mansur AH
     Mode of onset and triggers of severe asthma; the severe asthma clinic perspective.
     Ann Allergy Asthma Immunol. 2022 Jan 11. pii: S1081-1206(22)00008.
     PubMed    
     
     
     
268. WONG M, Han YY, Rosser F, Acosta-Perez E, et al
     Persistent overweight or obesity, lung function, and asthma exacerbations in Puerto Rican Youth.
     Ann Allergy Asthma Immunol. 2022 Jan 8. pii: S1081-1206(22)00005.
     PubMed     Abstract available
     
     
     
269. LOBATO M, Gaspar-Marques J, Carreiro-Martins P, Pinto PL, et al
     Secondary adrenal suppression related to high doses of inhaled corticosteroids in severe asthma patients.
     Ann Allergy Asthma Immunol. 2022 Jan 7. pii: S1081-1206(22)00002.
     PubMed    
     
     
     
270. BACHARIER LB
     Asthma Guidelines: Where to next?: A Perspective for Annals of Allergy, Asthma & Immunology.
     Ann Allergy Asthma Immunol. 2022 Jan 5. pii: S1081-1206(21)01342.
     PubMed    
     
     
     
271. WANG E, Zahid S, Moudgal AN, Demaestri S, et al
     Intimate Partner Violence and Asthma in Pediatric and Adult Populations: A Systematic Review.
     Ann Allergy Asthma Immunol. 2022 Jan 4. pii: S1081-1206(21)01343.
     PubMed     Abstract available
     
     
     
272. LAWRENCE MG, Teague WG, Feng X, Welch C, et al
     Interleukin-5 receptor alpha (CD125) expression on human blood and lung neutrophils.
     Ann Allergy Asthma Immunol. 2022;128:53-60.
     PubMed     Abstract available
     
     
     December 2021
273. BURROWS AG, Ellis AK
     Psychological Impacts of COVID-19 on people with Asthma, Allergic Rhinitis and Food Allergy.
     Ann Allergy Asthma Immunol. 2021 Dec 28. pii: S1081-1206(21)01310.
     PubMed    
     
     
     
274. FISCHELL SZ, Fischell JM, Olexa G, Callahan C, et al
     Impact of COVID-19 pandemic on frequency and severity of asthma exacerbations in an inner-city population.
     Ann Allergy Asthma Immunol. 2021 Dec 16. pii: S1081-1206(21)01308.
     PubMed    
     
     
     November 2021
275. CORREN J, Silver J, Molfino NA, Bogart M, et al
     A real-world study of ICS use in patients with severe eosinophilic asthma treated with mepolizumab.
     Ann Allergy Asthma Immunol. 2021 Nov 10. pii: S1081-1206(21)01219.
     PubMed     Abstract available
     
     
     
276. LU MA, Eckmann T, Ruvalcaba E, McQuaid EL, et al
     Family Management of Asthma in Head Start Preschool Children.
     Ann Allergy Asthma Immunol. 2021 Nov 10. pii: S1081-1206(21)01217.
     PubMed     Abstract available
     
     
     
277. CARR TF
     Treatment approaches for the patient with T2 low asthma.
     Ann Allergy Asthma Immunol. 2021;127:530-535.
     PubMed     Abstract available
     
     
     
278. OPPENHEIMER JJ, Leung DYM
     Asthma, in quest of optimizing care.
     Ann Allergy Asthma Immunol. 2021;127:517.
     PubMed    
     
     
     
279. LEVERONE N, Tran S, Barry J, Akuthota P, et al
     Diagnoses associated with peripheral blood eosinophilia: A 5-year review.
     Ann Allergy Asthma Immunol. 2021;127:597-598.
     PubMed    
     
     
     October 2021
280. LAFORCE C, Chipps BE, Albers FC, Reilly L, et al
     Albuterol/budesonide for the treatment of exercise-induced bronchoconstriction in patients with asthma: the TYREE study.
     Ann Allergy Asthma Immunol. 2021 Oct 23. pii: S1081-1206(21)01169.
     PubMed     Abstract available
     
     
     
281. GRANT T, Croce E, Matsui E
     Asthma and the Social Determinants of Health.
     Ann Allergy Asthma Immunol. 2021 Oct 18. pii: S1081-1206(21)01132.
     PubMed     Abstract available
     
     
     
282. AVDEEV SN, Pozdnakova AA, Gaynitdinova VV, Chikina SY, et al
     Asthma in older adults with severe COVID-19: clinical outcomes and predictors of mortality.
     Ann Allergy Asthma Immunol. 2021 Oct 17. pii: S1081-1206(21)01163.
     PubMed    
     
     
     
283. HOSSAIN R, Zhao F, Michenkova M, Kaelber D, et al
     Trends in racial disparities in asthma emergency department utilization during COVID-19.
     Ann Allergy Asthma Immunol. 2021 Oct 12. pii: S1081-1206(21)01159.
     PubMed    
     
     
     
284. TORRE AB, Dasgupta R, Eldeirawi KM, Nyenhuis SM, et al
     Positive associations of pollutants and aeroallergens with allergic rhinitis in adults with asthma.
     Ann Allergy Asthma Immunol. 2021 Oct 11. pii: S1081-1206(21)01157.
     PubMed    
     
     
     
285. STAMPFLI M, Frei R, Divaret-Chauveau A, Schmausser-Hechfellner E, et al
     Inverse associations between food diversity in the 2(nd) year of life and allergic diseases.
     Ann Allergy Asthma Immunol. 2021 Oct 11. pii: S1081-1206(21)01154.
     PubMed     Abstract available
     
     
     
286. BLEECKER ER, Gandhi H, Gilbert I, Murphy KR, et al
     Mapping Geographic Variability of Severe Uncontrolled Asthma in the United States: Management Implications.
     Ann Allergy Asthma Immunol. 2021 Oct 7. pii: S1081-1206(21)01125.
     PubMed     Abstract available
     
     
     September 2021
287. LAM RW, Inselman JW, Jeffery MM, Maddux JT, et al
     National decline in asthma exacerbations in US during COVID19 pandemic.
     Ann Allergy Asthma Immunol. 2021 Sep 25. pii: S1081-1206(21)01113.
     PubMed    
     
     
     
288. SACO T, Ugalde IC, Cardet JC, Casale TB, et al
     Strategies for choosing a biologic for your patient with allergy or asthma.
     Ann Allergy Asthma Immunol. 2021 Sep 23. pii: S1081-1206(21)01035.
     PubMed     Abstract available
     
     
     July 2021
289. BALL L, Velasquez SA, Jammal OMA, White AA, et al
     Atypical Eosinophilic Granulomatosis with Polyangiitis with Spontaneous Aspirin Reactivity and IgE Mediated Anaphylaxis.
     Ann Allergy Asthma Immunol. 2021 Jul 14. pii: S1081-1206(21)00502.
     PubMed    
     
     
     
290. UDOKO M, De Keyser H, Szefler SJ
     Should Asthmatic Children Simply be Treated as Little Adults?
     Ann Allergy Asthma Immunol. 2021 Jul 11. pii: S1081-1206(21)00498.
     PubMed    
     
     
     
291. FINEMAN S, Lee G, Hernandez-Truillo V, Chipps BE, et al
     From the Pages of Allergy Watch.
     Ann Allergy Asthma Immunol. 2021 Jul 8. pii: S1081-1206(21)00490.
     PubMed    
     
     
     May 2021
292. ABRAMS EM, Greenhawt M, Shaker M, Kosowan L, et al
     Primary Care Provider-Reported Prevalence of Vaccine and Polyethylene-Glycol Allergy in Canada.
     Ann Allergy Asthma Immunol. 2021 May 15. pii: S1081-1206(21)00357.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Asthma is free of charge.